rs201723414
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_031961.3(KRTAP9-2):c.317G>A(p.Gly106Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000742 in 1,612,936 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G106V) has been classified as Uncertain significance.
Frequency
Consequence
NM_031961.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000389 AC: 59AN: 151622Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000799 AC: 20AN: 250328Hom.: 4 AF XY: 0.0000960 AC XY: 13AN XY: 135484
GnomAD4 exome AF: 0.000778 AC: 1137AN: 1461202Hom.: 22 Cov.: 207 AF XY: 0.000736 AC XY: 535AN XY: 726850
GnomAD4 genome AF: 0.000389 AC: 59AN: 151734Hom.: 0 Cov.: 32 AF XY: 0.000405 AC XY: 30AN XY: 74124
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at